过去一年中添加的文章，按日期排序
Soluble Nogo-Receptor-Fc decoy (AXER-204) in patients with chronic cervical spinal cord injury in the USA: a first-in-human and randomised clinical trial
G Maynard, R Kannan, J Liu, W Wang… - The Lancet …, 2023 - thelancet.com
352 天前 - … limit axonal growth and synaptic plasticity, and in multiple animal models the decoy
protein supports axon growth … This protein biological agent blocks the three oligodendrocyte …
protein supports axon growth … This protein biological agent blocks the three oligodendrocyte …